Almirall : reduces its accident rate by 69% in Spain in 2015

• Almirall stands 85% below the official accident rate of the pharmaceutical sector in Spain
• The pharmaceutical plant has reduced its accident rate by 97% in the last 11 years
• The international affiliates reduce their accidents rate by 62% compared to 2014, achieving an all-time record.

Almirall S.A., a global pharmaceutical company based in Barcelona, has reduced its accident rate in Spain by 69% in 2015, which has meant that the company stands 85% below the official accident rate in the pharmaceutical sector in Spain. The results achieved largely owe themselves to the initiatives undertaken by Almirall to reinforce the safety of their staff.

'The excellent results achieved by the company are due to the number of actions that have been taken over the last few years in terms of safety and awareness-raising. In particular, during 2015 specific awareness-raising campaigns were implemented. In addition, at this point, we should highlight the important role played by our professionals with their commitment to health and safety ', said Cesar Hernandez, Head of Health, Safety and Environment of Almirall. 'These results place the accident rate of Almirall Spain at very low levels, 85% below the rate of the sector,' he adds.

Almirall is not only investing in Health and Satefy, its project aims to continuously improve its infrastructures, at the same time as training its professionals in terms of occupational risks so that they can improve their knowledge. In recent years, various specific campaigns have been launched, which have put more emphasis on areas where traditionally more accidents were recorded. 'Safety on the road' campaign for affiliates highlights, as well as 'For you, for everyone' campaign of the pharmaceutical plant and the 'Between you and the rules there is chemistry' campaign of the chemical plants.

'At Almirall we go above the classic concepts of health, safety and prevention, we not only try to avoid damage, something that we take for granted, but our commitment is found in our support of the wellbeing of our collaborators', affirms Cesar Hernandez.

1. The reference rate is the incidence rate of work leave due to accident, and the number of accidents per thousand workers

The chemical plants and the pharmaceutical plant in Spain are the places where the accident rate has been reduced most significantly. On the one hand, the chemical plants have achieved an incident rate in 2015 of 0,0, a milestone that has not been reached since 2009. Meanwhile, the pharmaceutical plant accumulates an accident rate reduction of 97% in the last 11 years: in 2015 there has been only one minor accident (one day off), compared to 32 incidents in 2004.

International overview

The pharmaceutical plant in Reinbek (Germany) has suffered only one minor accident during 2015.

Likewise, in the international affiliates of Almirall, a record in the accident rate has been achieved, as it has been 62% lower than in 2014, placing itself at 5.5. In the majority of the subsidiaries, 0 accident have been recorded, except in Mexico and Italy, where they have respectively suffered 2 and 1 minor accidents. As such, the accident rate has been reduced in both of these subsidiaries, passing from 31.1 to 18.2 in Mexico and from 21.0 to 15.7 in Italy.

Future plans

On the other hand, since last 2015, Almirall has been working on plans regarding the active aging of the population, with the aim to create and put into place actions to adapt the work of the older staff. These plans include training programs and monitoring of health and wellbeing, among other things, to support this age group and thus help them to continue bringing their knowledge to the company in the future in a healthy manner.

About Almirall

Almirall is a global company based in Barcelona dedicated to providing valuable medicines and medical devices through its R&D, agreements and alliances. Our work covers the whole of the drug value chain. A consolidated growth allows us to devote our talent and efforts towards specialty areas and particularly to further grow as a leading dermatology player. Our size enables us to be agile and flexible so that we can accomplish the purpose of taking our innovative products wherever they are needed.

Founded in 1943, Almirall is listed on the Spanish Stock Exchange (ticker: ALM) and it has become a source of value creation for society due to its vision and the commitment of its long-standing major shareholders. In 2014, its revenues totaled 1,407 million euros and, with more than 2,100 employees, it has gradually built up a trusted presence across Europe, as well as in the US and Mexico.

For more information, please visit www.almirall.com

Media contact:

Cohn & Wolfe Adriana Ibargüen [e-mail]

Tel.: [phone]